2003
DOI: 10.1002/jlcr.796
|View full text |Cite
|
Sign up to set email alerts
|

Quality control methods for 99mTc‐labeled exogenous natural surfactant (99mTc‐ENS)

Abstract: SummaryTo standardize the quality control for 99m Tc-ENS, the following methods were studied: (1) physical properties and pH, (2) radiochemical purity (chromatographic studies on Whatman-1 paper, or instant thin-layer chromatography and solvent extraction using different solvents and (3) rat biodistribution studies by intratracheal injection. The tolerance limits were fixed for each method. The radiopharmaceutical stability was also evaluated. The results showed that 99m Tc-ENS was a white suspension with a pH… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…Administration of exogenous surfactant has become standard therapy for infants with respiratory distress syndrome (RDS) or jaline membrane disease PROSURF has demonstrated in numerous clinical studies, using the appropriately marked product, a high distribution capacity at the alveolar level and resolution of respiratory failure. [17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36], Fig. No adverse effects could be found related to the administration of surfactants.…”
Section: Pulmonary Surfactant (Ps) Adjuvant Therapy In Sars-cov-2mentioning
confidence: 99%
“…Administration of exogenous surfactant has become standard therapy for infants with respiratory distress syndrome (RDS) or jaline membrane disease PROSURF has demonstrated in numerous clinical studies, using the appropriately marked product, a high distribution capacity at the alveolar level and resolution of respiratory failure. [17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36], Fig. No adverse effects could be found related to the administration of surfactants.…”
Section: Pulmonary Surfactant (Ps) Adjuvant Therapy In Sars-cov-2mentioning
confidence: 99%